Diabetic emergencies (ketoacidosis, hyperosmolar coma). Advanced hepatic or renal insufficiencies; pregnancy and nursing period.

Glibenclamide: Cautions

The relationship between the dose (or plasma level) and the antidiabetic effect is not clearly estbalished: according to certain studies, doses of more than 5 mg/day do not produce an additional beneficial effect.

Table of Contents | Indications | Pharmacology | Adverse Reactions & Interactions | Risk Groups | References